CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 819 enrolled
Drug / intervention
Text messagingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03724526
NCT03724526N/ACompleted
CompareCT.gov

Text Messaging and Cardiovascular Health in Diabetes Mellitus: A Randomized, Controlled Clinical Trial (TEACH Study)

Nanfang Hospital, Southern Medical University·interventional·Posted Oct 30, 2018·Updated Oct 24, 2022

In Brief

A clinical study evaluating Text messaging for Type 2 Diabetes Mellitus. Completed, enrolled 819 participants across 1 site.

Detailed Summary

The purpose of the study of the proposed randomized trial is to evaluate the effectiveness of automated mobile phone text message-based intervention in improving lifestyle modification, medication adherence and CVD risk factors (glycated hemoglobin \[HbA1C\], systolic blood pressure \[SBP\], and LDL-cholesterol) over 12 months among patients with type 2 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 30, 2018
Enrollment StartNov 1, 2018
Primary CompletionJun 22, 2022
Study CompletionJul 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 7.7 years ago

Interventions

Text messagingbehavioral

Intervention-Text messaging: Participants will receive regular text messages for 12 months. Each participant will receive 6 text messages per week. They will receive one general education about diabetes and CVD messages, one glucose control message, one blood pressure control message, one healthy eating message, one medication adherence message and one physical activity message per week. Control: The control group will receive the usual care.